HIV infections lowered by 30% in universal testing and treatment study

Communities in southern Africa which received a door-to-door HIV testing intervention and support for linkage to care had substantially lower HIV incidence, the Conference on Retroviruses and Opportunistic Infections (CROI 2019) in Seattle was told today.

This clear-cut effect was seen in the communities randomised to receive these interventions and treatment according to national guidelines, but as those guidelines changed to treatment-for-all early on in the life of the trial, the researchers believe it still provides evidence of the efficacy of the universal test and treat approach.

“Taken together with the findings of other studies, our results provide key evidence that the universal test and treat strategy can bring down incidence of new HIV infections, even in settings with severe generalised HIV epidemics,” Professor Richard Hayes of the London School of Hygiene and Tropical Medicine told a press conference.

PopART, also known as HPTN 071, was a large community-randomised trial carried out in Zambia and KwaZulu-Natal, South Africa. The study aimed to measure the impact on HIV incidence of household-based HIV testing and linkage to care by community health workers (lay counsellors) and immediate initiation of antiretroviral treatment delivered through routine health care services.

Scroll to Top

During the Canada Post strike announced September 25, 2025, the following measures will be undertaken to minimize service disruption to BC-CfE clients and providers.

  • The BC-CfE Laboratory has transitioned to private courier for delivery of outgoing reports and documents. Results required urgently can be faxed upon request. (Lab Contact Information: Phone 604-806-8775; FAX 604-806-9463)
  • The BC-CfE Drug Treatment Program (DTP) will fax outgoing forms and documents to the provider’s office. (DTP Contact Information: Phone 604-806-8515; FAX 604-806-9044)
  • St. Paul’s Hospital Ambulatory Pharmacy has transitioned to private courier for delivery of medications. We recommend requesting medication at least 2 weeks in advance in case of delivery delays, particularly to rural/remote parts of BC. (Contact Information: Phone 1-800-547-3622; FAX 604-806-8675)

During the Canada Post strike, we recommend that documents be faxed or couriered to our sites, versus utilization of regular mail service

The BC-CfE Laboratory is streamlining reporting processes for certain tests in order to simplify distribution and record-keeping, and to ensure completeness of results. Beginning September 2, 2025, results for the ‘Resistance Analysis of HIV-1 Protease and Reverse Transcriptase’ (Protease-RT) and ‘HIV-1 Integrase Resistance Genotype’ tests will be combined into a single ‘HIV-1 Resistance Genotype Report’.
For more details and example reports, please click on the button below